A new systematic literature review has been published evaluating more than a decade of research across 120-plus papers to assess omega-3 stearidonic acid's (SDA) role in addressing the persistent omega-3 nutrition gap.
The research focused particularly on Western populations.
The volume of SDA research has grown by 40% during the past ten years, reflecting mounting interest from both scientists and industry in scalable, non-marine omega-3 solutions.
The central finding was that SDA raises EPA levels in human blood at rates 2.5 to four times those of standard omega-3 ALA sources, such as flaxseed oil. It does so up to five to six times faster.
This efficiency stems from SDA bypassing a key rate-limiting liver enzyme in the ALA-to-EPA conversion pathway — a well-documented metabolic bottleneck that has long hampered plant-based omega-3 strategies.
Buglossoides arvensis (Ahiflower) is identified in the review as the richest natural SDA source, with echium, hemp and black currant seed oils also covered.
Research cited in the paper demonstrates that Ahiflower oil achieves EPA status improvements comparable to EPA/DHA dietary trials and supports DHA turnover in brain and liver tissue at rates similar to DHA itself, with as little as 1 g per day meeting the brain's estimated daily DHA requirement endogenously.
The review also consolidates evidence for SDA's anti-inflammatory profile, including inhibition of pro-inflammatory signalling markers, improved vascular endothelial function and reduced inflammasome activation.
The authors conclude that SDA-rich plant oils (particularly when combined with algal DHA) can sustain physiologically sufficient EPA and DHA levels, potentially reducing dependence on marine sources.
For nutraceutical brands navigating sustainability pressures and consumer demand for clean, shelf-stable formats, the review offers a well-evidenced scientific foundation.
Greg Cumberford, Science Lead at Natures Crops International, said: "This first systematic literature review of omega-3 SDA adds important support for brands, brand holders and co-manufacturers in supplements, foods and beverages."
He added the research was particularly relevant for supplement, food and beverage manufacturers who have been seeking omega-3 delivery "at no trade-offs to taste or consumer convenience."
The researchers also call for further research into population-specific effects and drug-nutrient interactions to support broader application across food and feed industries.